JPRN-UMIN000001731未知1 期
Cancer vaccination therapy by using VEGFRs-targeted peptides in the patients who have received trans-arterial chemo-embolization (TACE) against hepatocellular carcinoma -A randomized double blind study- - Cancer vaccination therapy in the patients who have received trans-arterial chemo-embolization (TACE) against hepatocellular carcinoma
Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences Kumamoto University0 个研究点目标入组 30 人开始时间: 2009年2月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients have more than 10 tumors in the liver before TACE treatment. 2. Patients have major portal vein thrombosis. 3. Patients have extrahepatic metastasis. 4. Patients have uncontrollable associated cancer. 5. Patients have uncontrollable severe infectional diseases. 6. Patients have trauma. 7. Patients who are treated with steroid or immunotherapy during clinical trial. 8. Pregnancy or lactation. 9. Patients who are inappropriate.
研究者
相似试验
未知
1 期
Cancer vaccination therapy by using tumor-associated antigen GPC3-targeted peptide in the partients who have received trans-arterial infusion chemotherapy against advanced hepatocellular carcinoma -A randomized double blind studyhepatocellular carcinomaJPRN-UMIN000001732Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences Kumamoto University20
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent ovarian cancer using HLA-A*0201 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomadvanced/recurrent ovarian cancer with the conditions of unremoval by surgery, or refractory, chemo-resistant disease.JPRN-UMIN000003860Iwate Medical University School of Medicine Department of Obstetrics and Gynecology30
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent cervical cancer using HLA-A*0201 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomadvanced/recurrent cervical cancer with the conditions of unremoval by surgery, or refractory, chemo-resistant disease.JPRN-UMIN000003903Iwate Medical University School of Medicine department of Obastetrics and Gynecology30
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent cervical cancer using HLA-A*2402 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomJPRN-UMIN000003902Iwate Medical University School of Medicine department of Obstetrics and Gynecology30
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent ovarian cancer using HLA-A*2402 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomadvanced/recurrent ovarian cancer with the conditions of unremoval by surgery, or refractory, chemo-resistant disease.JPRN-UMIN000003862Iwate Medical University School of Medicine department of obstetrics and gynecology30